JAN 30, 2019 12:22 PM PST

Doctors Find New Test for Brain Cancer

WRITTEN BY: Amy Loriaux

Doctors from the Memorial Sloan Kettering Cancer Center in New York recently published a paper in Nature detailing what they believe is a novel, low-evasive test to determine the presence of brain cancer. Brain cancer, notoriously difficult to treat, currently can only be tested by biopsy, which is highly invasive and involves surgery. While many cancers can be determined by a simple blood test, brain cancer cannot, until now. Dr. Ingo Mellinghoff and colleagues believe that they could use another liquid biopsy: cerebral spinal fluid (CSF).

Photo source: UnSplash.com

CSF is a clear fluid that bathes the brain and spinal cord. It flushes out waste products, brings in nutrients from the blood, and overall cushions the central nervous system (CNS). Doctors take a sample of CSF through a relatively simple procedure called a lumbar puncture (aka "spinal tap"). The procedure uses local anesthesia and therefore patients do not have to be put under general anesthesia. 

The trouble with blood tests is that they rely on circulating tumor DNA (ctDNA). The ctDNA in tumors of other types of cancers are much easier to detect through blood sampling followed by genotyping the ctDNA for diagnosis. In order to do that for brain tumors, a tissue biopsy is currently needed. However, ctDNA of patients with brain tumors is much harder to find in blood. So research scientists decided to look for another liquid and thought they might be able to find ctDNA of brain tumors through CSF.

To see if they could indeed find ctDNA for brain tumors from CSF, the group tested for the presence of ctDNA of a particularly common type of brain tumor, glioma, from 85 patients who showed neurological signs or symptoms for the disease. They found that tumor-derived DNA was detected in CSF from 42 out of 85 patients (49.4%). It was also associated with disease outcomes and progression. 

Photo source: UnSplash.com

Gliomas are the most common form of brain cancer representing around 80% of all malignant brain tumors. It is rarely curable. The prognosis is generally poor. A patient with glioma is usually given a year to a year and a half to survive. Typical treatment includes chemotherapy, radiation, and surgery. The authors of the current study believe, that with earlier detection could you could start therapies much earlier in order increase the survival of the patient. Not only that, but this technique could help researchers learn more about the genetic profile of gliomas which could lead to more personalized, gene-based therapies.

The video below goes through how liquid biopsies are helping doctors detect ctDNA in blood. The current study used CSF but the methods are essentially the same.

Video source: YouTube.com

SourcesNature, US National Library of Medicine, MayoClinic.orgScience Translational Medicine, Cancer Genetics, The Washington Post, en.Wikipedia.org - Glioma

About the Author
PhD
I currently work at a small CRO involved in clinical trial management.
You May Also Like
AUG 08, 2022
Immunology
Controls and Calibrators for Measurement Assurance in Flow Cytometry: New Applications and New Requirements
AUG 08, 2022
Controls and Calibrators for Measurement Assurance in Flow Cytometry: New Applications and New Requirements
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass ...
SEP 05, 2022
Cancer
A Look at Occupational Cancers on Labor Day
SEP 05, 2022
A Look at Occupational Cancers on Labor Day
Today marks Labor Day in the United States, an annual celebration of the American workforce and its contribution to the ...
SEP 19, 2022
Genetics & Genomics
CGP: Simplifying the path from tumor to treatment
SEP 19, 2022
CGP: Simplifying the path from tumor to treatment
The promise of NGS in personalized cancer care For years, next-generation sequencing (NGS) has enabled oncologists to id ...
OCT 06, 2022
Cancer
Caregivers Need Exercise Too
OCT 06, 2022
Caregivers Need Exercise Too
We all know that exercise and a good diet benefit overall health.  Several studies indicate that cancer survivorshi ...
NOV 09, 2022
Genetics & Genomics
Want to Study Copy Number Alterations in Cells? Bring MACHETE
NOV 09, 2022
Want to Study Copy Number Alterations in Cells? Bring MACHETE
Sure, MACHETE is a cool name, but the researchers that developed the technique are hoping people don't focus solely on t ...
NOV 23, 2022
Technology
Hyperthermic Nanoparticles for Cancer Treatment
NOV 23, 2022
Hyperthermic Nanoparticles for Cancer Treatment
Hyperthermia (excess heats) refers to the use of high temperatures to treat cancer. When used to treat tumors locally, h ...
Loading Comments...